Ticker
CEROCompany Name
CERO THERAPEUTICS HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 6.2M | $ 3.3M | 53.25% |
3/31/2025 | $ 7.99M | $ 5.2M | 65.11% |
12/31/2024 | $ 6.21M | $ 3.33M | 53.6% |
9/30/2024 | $ 6.49M | $ 3.38M | 52.07% |
6/30/2024 | $ 7.37M | $ 3.65M | 49.48% |
3/31/2024 | $ 9.05M | $ 4.59M | 50.74% |
12/31/2023 | $ 8.56M | $ 96.87K | 1.13% |
9/30/2023 | $ 8.47M | $ 119.01K | 1.41% |
6/30/2023 | $ 14.11M | $ 105.23K | 0.75% |
3/31/2023 | $ 14.43M | $ 178.09K | 1.23% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CERO THERAPEUTICS HOLDINGS INC is calculated as follows: CashnEq [ $ 0 ] / Assets [ $ 25K ]
(=) Cash to Assets [ 0% ]
Minimum
Jun 30, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |